Back to Results
First PageMeta Content
Medical signs / Glycosaminoglycans / Low molecular weight heparin / Anticoagulant / Deep vein thrombosis / Pulmonary embolism / Thrombosis / Partial thromboplastin time / Hemodialysis / Medicine / Heparins / Hematology


Document Date: 2014-09-29 18:45:31

Open Document

File Size: 290,64 KB

Share Result on Facebook

/

IndustryTerm

nonstandard solution / indication dependent protocol / heparin sodium protocol / intravenous heparin sodium protocol / volumetric device / sodium solution / Treatment of Acute Coronary Syndrome / /

MedicalCondition

paralysis / arterial thrombosis / arterial thromboembolism / disease / ST Elevation Myocardial Infarction / Acute Coronary Syndrome / Severe uncontrolled hypertension / oesophageal varices / extracorporeal thrombosis / unstable angina / Non-ST Elevation Myocardial Infarction / Deep vein thrombosis / venous thromboembolism / Pulmonary embolism / Atrial fibrillation / thrombus / thrombosis / disorders / acute myocardial infarction / /

MedicalTreatment

angioplasty / bypass / cannula / intravenous infusion / surgery / /

Organization

EVIDENCE NSW Ministry of Health Policy National Safety / SESLHD Clinical and Quality Council / Ministry of Health / Medicines Committee / /

Person

George Rubin / Julie Thompson Drug / /

Position

Author / EXECUTIVE CLINICAL SPONSOR Director of Clinical Governance AUTHOR Julie Thompson Drug / Governor / Professor / Coordinator / syringe driver / Clinical Governance AUTHOR / /

Product

sodium chloride / heparin sodium 25 / 000 Units / IM injection / Heparin Sodium / /

Technology

defined protocol / relevant intravenous heparin sodium protocol / heparin sodium protocol / indication dependent protocol / /

SocialTag